Statistics

Total Visits

Views
Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013-01.7

Select a period of time:

Number of views in the range

Views
Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013-01.2

Views

Views
October 20230
November 20231
December 20230
January 20241
February 20240
March 20240
April 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
 

Top cities views

Views
Ashburn1
Boardman1